Epstein Secrets

C ACCT. For the Period 2/1/12 to 2/29/12 INFLOWS & OUTFLOWS Type Settle Date Selection Method 2/6 2/6 2/6 2/10 2/10 2/15 2/15 2/27 2/27 FX Fwd Contract FX Fwd Contract Spot FX Accrued Int Paid Corporate Interest Accrued Int Paid Corporate Interest Accrued Int Paid Accrued Int Recd Total Infl

information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 116.47 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 P FIRST REPUBLIC BANK SAN FRAN HSBC MARKET PLUS SPX 05

Selection Method 3/1 3/1 3/1 3/5 3/6 3/6 3/12 3/15 3/15 Corporate Interest Interest Income Div Domest Accrued Int Recd FX Fwd Contract FX Fwd Contract Corporate Interest Foreign Dividend Spot FX Description AMERICAN AXLE & MFG INC 7 7/8% MAR 1 2017 DTD 2/27/2007 (ID: 02406P-AF-7) DEPOSIT SWEE

information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 126.00 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 P P DOLLAR GENERAL CORP DUNKIN BRANDS GROUP INC HSBC

0.00 JP MORGAN SECURITIES LLC (BIDL) TRADE DATE 04/02/12 FACE VALUE 8,000,000.00 (ID: 81743P-AH-9) 6/11 6/11 6/11 6/11 6/12 6/15 6/20 6/20 FX Fwd Contract FX Fwd Contract Corporate Interest Corporate Interest Corporate Interest Foreign Dividend Corporate Interest Corporate Interest SETTLE FORWAR

information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 144.38 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 FACEBOOK INC-A 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/

nding relieving assets from your Portfolio Activity Detail - Mexican INFLOWS & OUTFLOWS Per Unit Type Settle Date Selection Method 7/23 7/23 FX Fwd Contract Spot FX Total Inflows & Account Description SETTLE FORWARD CURRENCY CONTRACT USD CONTRACT RATE : 13.735000000 VALUE 7/23/12 (ID: OMXNPR-AA-7)

information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A1-A7-6 FACEBOOK INC-A 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/